The largest database of trusted experimental protocols

4 protocols using gm01651

1

Profiling Cell Viability Across Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH3T3 mouse fibroblasts (CRL-1658), CaCo2 cells human colorectal adenocarcinoma (HTB-3), and the N2a neuroblastoma cell line (CCL-131) were obtained from the American Type Culture Collection and were validated by genomic PCR. Primary human fibroblasts (GM01651) were from Coriell Repository. Cells were cultured to full confluence in a 37 °C incubator with 5% CO2 in complete Dulbecco’s modified Eagle’s medium (DMEM, Sigma #D5030) supplemented with 10% heat-inactivated newborn calf serum (HyClone #SH30401.02HI), 1% penicillin/streptomycin/fungizone (Invitrogen, #10072322). All the cell lines were tested for mycoplasma contamination using DNA staining protocol with Hoechst 33258 dye and none of them was found positive. Knock-down of Ncor1 was done using lentiviral mediated shRNA (SHCLNG-NM_011308) from the Sigma Mission library following standard procedures. The efficiency of knock-down was tested by immunoblot. Cell viability was measured using the CellTiter-Blue kit (Promega, #G9241) 24 h after the addition of the different stressors according to the manufacturer’s instructions. All cell lines were validated by genomic PCR.
+ Open protocol
+ Expand
2

Fibroblast Cell Lines for DYT1 Dystonia Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human skin fibroblasts of control fibroblasts (HF6, HF19) and of DYT1 patient's fibroblast (HF48) were generated in Dr. Breakefield ‘s laboratory as described previously [42] (link), under IRB approved guidelines. Fibroblast control cell lines GM00023, GM00024, GM01651, GM02912, and DYT1 patient fibroblast cell lines GM02551, GM03208, GM032011, GM02306 were purchased from Coriell Institute for Medical Research (Camden, NJ). The Coriell Cell Repository maintains the consent and privacy of the donor fibroblast samples. DYT1 patient fibroblast cells, FFF13111983 [43] (link), were provided from Dr. Mirella Filocamo (Biobank from Patients affected by Genetic Diseases, L'Istituto Giannina Gaslini, Genoa, Italy), a member of the Telethon Network of Genetic Biobanks (project no. GTB12001). The primary fibroblast cells were grown in culture, as described [24] (link). For more information about the human fibroblast cell lines, see Table S1. Human fibroblast cells were seeded, and incubated overnight before the cAMP assay.
+ Open protocol
+ Expand
3

Comparison of Fibroblast Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven primary human skin fibroblast lines—GM09503 (passage frozen (P), P3), GM01652 (P11), GM01651 (P14), GM00288 (P9), GM01681 (P12), GM01680 (P12), and GM03525 (P7) —were purchased from the Coriell Institute (Camden, NJ, USA). The fibroblasts were cultured in MEM (Gibco) supplemented with 15% (v/v) heat inactivated FBS (Gibco), 1% (v/v) MEM non-essential amino acids (Gibco), and 1% (v/v) Pen-Strep (Gibco) in the incubator (37 °C, 5% CO2). The cells within 7 passages from the initial P were used for RT-qPCR assays.
+ Open protocol
+ Expand
4

Dermal Fibroblast Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary dermal fibroblast cells from probands and parents were cultured from 3mm punch biopsies taken from the forearm. Unaffected pediatric primary dermal fibroblast cell lines GM05399 (Control 1) and GM01651 (Control 2) (Coriell Institute for Medical Research, Camden, NJ) were used as controls. Fibroblasts were cultured in high glucose DMEM (11965092) with 10% fetal bovine serum (FBS, 10082), 1% nonessential amino acids (11140050,) and 1% pen/strep (1507000063) (all obtained from Gibco/Thermo Fisher Scientific, Gaithersburg, MD) (complete DMEM) at 37°C with 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!